Bharat Biotech’s US-Based Partner Ocugen To Seek Emergency Use Nod From Health Canada For CovaxinBharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus. (Swarajya Magazine)

Hyderabad-based vaccine maker Bharat Biotech's United States (US)-based partner for COVID-19 Covaxin, Ocugen is set to seek an emergency use approval for the vaccine from the Canadian health authorities, reports Times of India.

Ocugen has said that it has already initiated discussions with Health Canada and will be pursuing an expedited authorisation for Covaxin under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19 in Canada.

It should be noted that Ocugen acquired Covaxin's rights for the Canadian market only recently. It said last week that it has made an upfront payment of $15 million to Bharat Biotech for the rights of the vaccine for the Canadian market.

In addition to this, Ocugen will also be making a milestone payment of $10 million to Bharat Biotech within 30 days of the first commercial sale of Covaxin in Canada.

Just as in the case of the deal signed between Ocugen and Bharat Biotech for the US market, Ocugen will be retaining 45 per cent of the profits from Covaxin's sales in Canada, while Bharat Biotech will receive the remaining 55 per cent of the profits.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement